Can Complexed Prostate Specific Antigen Enhance Prostate Cancer Detection in Japanese Men?

This publication has 15 references indexed in Scilit:

• Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial
  Urology, 2002
• Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis
  Urology, 2002
• Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 men
  Urology, 2002
• Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigen
  Urology, 2002
• Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter
  Urology, 2002
• Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?
  Urology, 2002
• Comparative Analysis of Complexed Prostate Specific Antigen, Free Prostate Specific Antigen and Their Ratio in Detecting Prostate Cancer
  Journal of Urology, 2002
• COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCER
  Journal of Urology, 2000
• USE OF LOWER PROSTATE SPECIFIC ANTIGEN CUTOFFS FOR PROSTATE CANCER SCREENING IN BLACK AND WHITE MEN
  Journal of Urology, 1998
• Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements
  JAMA, 1997